Search Results 161-170 of 16566 for Acrivastine

  1. Clinical trials - Oncology (Medical)

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  2. Carboprost (intramuscular route) - Side effects & dosage - Mayo Clinic

    Carboprost is given by injection to cause abortion. It is an oxytocic, which means it acts by causing the uterus to contract the way it does during labor and ...

  3. Etranacogene dezaparvovec-drlb (intravenous route) - Side effects & uses - Mayo Clinic

    Etranacogene dezaparvovec-drlb injection is used to treat hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have ...

  4. Revefenacin (inhalation route) - Mayo Clinic

    It relieves cough, wheezing, and troubled breathing by increasing the flow of air through the bronchial tubes. This medicine is available only with your ...

  5. Isatuximab-irfc (intravenous route) - Side effects & uses - Mayo Clinic

    Isatuximab-irfc injection is used in combination with pomalidomide and dexamethasone to treat multiple myeloma (a type of bone marrow cancer) in patients who ...

  6. A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer

    A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic ...

  7. A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150] - Mayo Clinic

    A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...

  8. Capivasertib (oral route) - Side effects & dosage - Mayo Clinic

    Capivasertib is used in combination with fulvestrant to treat HR-positive, HER-2 negative breast cancer that is advanced or metastatic (cancer that has spread) ...

  9. Neurology - Clinical trials - Mayo Clinic

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  10. A Study To Evaluate The Effectiveness, Safety, And Tolerability Of BOS-589 In The Treatment Of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    About this study. The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel ...